Simplex Trading’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3K | Buy |
+18,400
| New | +$21.9K | ﹤0.01% | 6848 |
|
|
2025
Q4 | – | Sell |
-13,800
| Closed | -$22K | – | 8503 |
|
|
2025
Q3 | $22K | Buy |
13,800
+7,400
| +116% | +$12.1K | ﹤0.01% | 7235 |
|
|
2025
Q2 | $8K | Buy |
6,400
+2,800
| +78% | +$4.19K | ﹤0.01% | 7439 |
|
|
2025
Q1 | $5K | Sell |
3,600
-7,600
| -68% | -$9.65K | ﹤0.01% | 7515 |
|
|
2024
Q4 | $14K | Sell |
11,200
-4,700
| -30% | -$7.29K | ﹤0.01% | 6929 |
|
|
2024
Q3 | $29K | Sell |
15,900
-24,800
| -61% | -$98K | ﹤0.01% | 6368 |
|
|
2024
Q2 | $301K | Buy |
40,700
+2,000
| +5% | +$16.5K | ﹤0.01% | 4217 |
|
|
2024
Q1 | $303K | Buy |
38,700
+38,200
| +7,640% | +$246K | ﹤0.01% | 4379 |
|
|
2023
Q4 | $2K | Sell |
500
-4,800
| -91% | -$24.7K | ﹤0.01% | 8210 |
|
|
2023
Q3 | $31K | Sell |
5,300
-9,100
| -63% | -$60.6K | ﹤0.01% | 6215 |
|
|
2023
Q2 | $106K | Buy |
14,400
+9,400
| +188% | +$80K | ﹤0.01% | 5010 |
|
|
2023
Q1 | $47K | Sell |
5,000
-4,700
| -48% | -$49.6K | ﹤0.01% | 5980 |
|
|
2022
Q4 | $103K | Sell |
9,700
-90,300
| -90% | -$916K | ﹤0.01% | 5039 |
|
|
2022
Q3 | $738K | Buy |
100,000
+50,100
| +100% | +$311K | ﹤0.01% | 3010 |
|
|
2022
Q2 | $240K | Sell |
49,900
-7,300
| -13% | -$41.4K | ﹤0.01% | 4388 |
|
|
2022
Q1 | $292K | Sell |
57,200
-8,700
| -13% | -$45.8K | ﹤0.01% | 4589 |
|
|
2021
Q4 | $396K | Sell |
65,900
-48,000
| -42% | -$360K | ﹤0.01% | 4141 |
|
|
2021
Q3 | $881K | Hold |
113,900
| – | – | ﹤0.01% | 3255 |
|
|
2021
Q2 | $900K | Buy |
+113,900
| New | +$894K | ﹤0.01% | 3272 |
|
|
2021
Q1 | – | Sell |
-726
| Closed | -$566K | – | 8752 |
|
|
2020
Q4 | $566K | Buy |
726
+697
| +2,403% | +$7.57K | ﹤0.01% | 3264 |
|
|
2020
Q3 | $28K | Buy |
+29
| New | +$320 | ﹤0.01% | 6121 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$3K | – | 6965 |
|
|
2018
Q3 | $3K | Sell |
1
-5
| -83% | -$102 | ﹤0.01% | 6931 |
|
|
2018
Q2 | $11K | Buy |
+6
| New | +$76 | ﹤0.01% | 6273 |
|
|
2016
Q4 | – | Sell |
-5
| Closed | -$1K | – | 5796 |
|
|
2016
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 5233 |
|
|
2016
Q2 | $1K | Buy |
+5
| New | +$279 | ﹤0.01% | 5197 |
|
|
2016
Q1 | – | Sell |
-4
| Closed | -$9K | – | 5546 |
|
|
2015
Q4 | $9K | Buy |
+4
| New | +$266 | ﹤0.01% | 3366 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$3K | – | 5474 |
|
|
2015
Q2 | $3K | Buy |
+1
| New | +$85 | ﹤0.01% | 3987 |
|
Other funds holding ATNM
VCM
GS
VFT
Simplex Trading's ATNM Position: Q2 2025 in Review
Simplex Trading sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 2,966 shares — an estimated $4.44K sold.
Simplex Trading first reported a position in ATNM in Q1 2015 and held it in 19 quarters. The position peaked at $294K in Q3 2022. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.
- Simplex Trading reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 2,966 Actinium Pharmaceuticals shares in Q2 2025, an estimated $4.44K.
- Simplex Trading first reported a position in Actinium Pharmaceuticals in Q1 2015 and held it in 19 quarters.
- Simplex Trading's Actinium Pharmaceuticals position peaked at $294K in Q3 2022.
- 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.